Kjetil Taskén

Also affiliated with University of Oslo, Institute of Clinical Research, Cancer Registry of Norway, Matrix Research (United States)

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies”.

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies

Molecular Oncology(2021)10.1002/1878-0261.13153

N/A

0DataRank · unranked

17 citations

Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien +6 more

Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1221

N/A

0DataRank · unranked

12 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.14.488428

N/A

0DataRank · unranked

1 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Ishwarya Murali, Stacey M. Fernandes +11 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718.v1

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Cyclic nucleotide phosphodiesterases as drug targets

Pharmacological Reviews(2025)10.1016/j.pharmr.2025.100042

N/A

0DataRank · unranked

28 citations

Viacheslav O. Nikolaev, Leila Gobejishvili, Claire Lugnier, Christian Heßlinger, Peter Nickolaus +24 more

The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency

Frontiers in Immunology(2025)10.3389/fimmu.2024.1447995

N/A

0DataRank · unranked

2 citations

Noriko Mitsuiki, Florian Emmerich, Virginia Patiño, Hanns‐Martin Lorenz, Olaf Neth +6 more